Eyenovia announces new $25 million credit facility with silicon valley bank

New york, may 10, 2021 (globe newswire) -- eyenovia, inc. (nasdaq: eyen), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (map™) therapeutics, today announced that the company has entered into a new $25 million credit financing facility with silicon valley bank (svb).
EYEN Ratings Summary
EYEN Quant Ranking